Can You Take Prednisone While Pregnant?

Prednisone is considered compatible with pregnancy when a mother’s medical condition genuinely requires it, and it remains one of the more commonly prescribed corticosteroids for pregnant women with autoimmune diseases or severe asthma. That said, “compatible” does not mean risk-free. The dose, the timing, and the underlying disease all shape the balance of benefit and harm, and the details matter more than a simple yes-or-no answer suggests.

Why Prednisone Gets a Pass That Other Steroids Do Not

The placenta contains an enzyme called 11-beta-hydroxysteroid dehydrogenase type 2 (usually shortened to 11β-HSD2) that acts as a metabolic gatekeeper. When prednisone or its active form, prednisolone, reaches the placenta, this enzyme converts much of it into an inactive form before it can cross to the fetus.¹ The result is that the fetus is exposed to only a fraction of the maternal dose. Lab studies have confirmed that this enzyme metabolizes prednisolone, dexamethasone, betamethasone, and beclomethasone, though it does not break down every synthetic steroid equally.²

This is a key reason prednisone and prednisolone are preferred over dexamethasone or betamethasone when the goal is to treat the mother’s condition rather than the fetus. Dexamethasone and betamethasone cross the placenta much more freely, which is exactly why they are the steroids chosen when clinicians want to reach the fetus directly, for instance to accelerate fetal lung maturity before a preterm delivery. When the mother needs anti-inflammatory treatment for her own body, prednisone keeps more of the drug on her side of the equation.

There is a catch, though. The placental enzyme has a limited capacity. At high doses or with prolonged use, the enzyme can become saturated, meaning more active drug passes through to the fetus than the usual small fraction.³ This is one of the central reasons clinicians aim for the lowest effective dose.

The Cleft Palate Question

For years, a lingering concern about first-trimester corticosteroid use centered on a possible increase in oral clefts, specifically cleft lip and cleft palate. Early case-control studies and animal data fueled this worry, and you will still find it mentioned in drug references and pregnancy guides. But the more recent and larger human studies have been reassuring.

A large population-based study looking at corticosteroid use from four weeks before conception through 12 weeks after found no association between corticosteroid exposure and cleft lip with or without cleft palate, and no association with cleft palate alone. The finding held regardless of the route of administration — systemic, inhaled, nasal, or topical — and regardless of the specific steroid, including prednisone.⁴ A separate study similarly found no statistically significant increase in cleft risk with corticosteroid use during pregnancy. The one elevated number in that analysis, for dermatologic (skin-applied) corticosteroids and cleft lip, was judged by the researchers to likely be a statistical artifact from running many comparisons rather than a true causal signal.⁵

The upshot is that while some older references still list oral clefts as a potential risk, the best available human data does not support a meaningful increase. This does not mean the risk is zero with absolute certainty, because proving a negative in birth defect research is nearly impossible. But the numbers are consistently reassuring across the studies that have looked hardest at this question.

Where the Real Risks Show Up

If cleft palate is largely a settled question, the risks that do warrant attention are mostly about dose-dependent maternal and pregnancy complications rather than structural birth defects.

Preterm birth and low birth weight are the outcomes that come up most often in research on corticosteroid use during pregnancy. In women with systemic lupus erythematosus, higher average daily doses of glucocorticoids during pregnancy were associated with more preterm births and more low-birth-weight babies. One study of this population identified a threshold around 10 mg per day of prednisone equivalent, above which preterm birth risk increased substantially.⁶ Similarly, research in women with rheumatoid arthritis found that higher daily and cumulative prednisone doses were linked to shorter pregnancies by roughly two to two and a half weeks, even after adjusting for disease severity.⁷

Here is the tricky part, and researchers have grappled with it for decades. Women who need higher steroid doses tend to have more active, more severe disease. Severe autoimmune disease itself raises the risk of preterm birth, low birth weight, and preeclampsia. That makes it very hard to separate the effect of the drug from the effect of the disease it is treating. A thorough review of the evidence concluded that disease severity, not corticosteroids themselves, appears to be responsible for much of the reported association with preterm birth. The review also suggested that any link between steroids and low birth weight was most likely driven by shorter pregnancies rather than a direct effect on fetal growth.⁸ Researchers studying this in rheumatoid arthritis explicitly noted that adjusting for disease severity tended to shrink the apparent effect of the drug, suggesting that some of what looks like a drug risk is actually a disease risk.⁹

This does not let prednisone completely off the hook. A meta-analysis of studies that mostly used higher-dose steroids found increased rates of gestational diabetes, preeclampsia, and preterm birth in women receiving glucocorticoids.¹⁰ The practical conclusion is that prednisone at low doses, especially below roughly 10 mg per day, carries a substantially different risk profile than prednisone at 20, 30, or 40 mg per day. The two situations should not be treated as the same conversation.

Conditions That Often Require It

The most common reasons pregnant women end up on prednisone are autoimmune diseases and severe asthma. Lupus flares during pregnancy can threaten both the mother and the pregnancy, and guidelines advise treating non-kidney lupus flares with the lowest effective dose of prednisone.¹¹ For women with severe asthma, uncontrolled disease poses a real danger during pregnancy: asthma attacks restrict oxygen to the fetus and are associated with preeclampsia and poor growth. A study of 56 pregnancies in women with severe asthma requiring prednisone or inhaled beclomethasone found no malformations, no neonatal deaths, and no maternal deaths, and concluded that these steroids were appropriate therapy during pregnancy.¹²

There is evidence that pregnant women with asthma may actually be undertreated because of fear about steroid use. Research has shown that pregnant women are less likely to receive oral steroids for emergency asthma management compared to non-pregnant women.¹³ This undertreatment can itself be dangerous. A severe asthma attack that deprives the fetus of oxygen is a more immediate and concrete threat than the theoretical risks of a short course of prednisone.

Other conditions that may require corticosteroids during pregnancy include inflammatory bowel disease, rheumatoid arthritis, organ transplant maintenance, and antiphospholipid syndrome. In each case, the guiding principle is the same: uncontrolled disease is typically more dangerous than carefully managed steroid use.

Keeping the Dose Low and Considering Alternatives

Because the risks of prednisone during pregnancy are so dose-dependent, clinicians often try to use steroid-sparing medications to keep the prednisone dose as low as possible. Azathioprine is widely considered the immunosuppressive drug of choice in pregnancy for this purpose. It has a long track record of use in pregnant women with autoimmune conditions and allows doctors to reduce or eliminate prednisone in many cases.¹⁴ Cyclosporine and tacrolimus can also serve as steroid-sparing agents, although there is less experience with them in pregnancy.¹⁵

The strategy in practice often looks something like this: get the disease under solid control before conception, ideally with a steroid-sparing agent, then use the pregnancy period to keep prednisone at the minimum necessary dose, or stop it entirely if the disease allows. For women who conceive during a flare and need prednisone to bring things under control, the goal shifts to tapering down as quickly as safely possible.

Maternal Infection Risk During Pregnancy

One underappreciated side effect of prednisone during pregnancy is its effect on the mother’s immune system. Pregnancy already modulates immune function, and adding a corticosteroid on top of that creates additional vulnerability. A large cohort study of pregnant women with autoimmune inflammatory conditions found that higher daily steroid doses were associated with an increased risk of serious infections during pregnancy.¹⁶ Serious infections during pregnancy can trigger preterm labor and other complications, so this is not just a maternal comfort issue — it feeds back into pregnancy outcomes.

Practical steps to manage this include staying current on vaccinations before pregnancy (since live vaccines are generally off-limits during pregnancy), prompt treatment of any infections that arise, and awareness that symptoms of infection like fever or malaise deserve quicker medical attention than they might in a healthy non-pregnant person.

What Happens to the Baby After Delivery

Most babies born to mothers who took prednisone during pregnancy do not show signs of adrenal suppression. The majority of neonates in this situation have normal adrenal function at birth.¹⁷ However, when mothers have been on high doses or prolonged courses, some babies can develop transient adrenal insufficiency. In rare cases, this can be serious enough to require treatment. One published case involved life-threatening adrenal suppression in a newborn whose mother received high-dose methylprednisolone (a related but more potent steroid) late in pregnancy, though the baby recovered with hydrocortisone treatment.¹⁸

Neonatal teams are generally aware of this possibility. When a mother has been on substantial steroid doses near delivery, the pediatric team will often monitor the baby’s cortisol levels and watch for signs like poor feeding, low blood sugar, or low blood pressure in the first days of life. For mothers on low-dose prednisone, this level of surveillance usually is not needed.

Regarding longer-term neurodevelopmental effects, a study looking at prednisone exposure in early pregnancy found no association with developmental problems in infancy.¹⁹ This is reassuring, though long-term follow-up data remains relatively limited, and most of what exists focuses on the more potent steroids given for fetal lung maturation rather than on maternal prednisone use specifically.

Breastfeeding on Prednisone

Mothers who continue prednisone after delivery often worry about whether the drug passes into breast milk. The answer is that it does, but in very small amounts. A pharmacokinetic study found that on average only about 0.025% of the mother’s prednisolone dose was recovered in breast milk, a level the researchers considered clinically insignificant for the nursing infant.²⁰ At typical therapeutic doses, the amount a baby would ingest through nursing is tiny compared to what the baby’s own body produces naturally.

For women on higher doses, some experts have suggested waiting a few hours after taking the medication before breastfeeding, since drug levels in milk peak and then fall. But for most women on standard doses of prednisone, breastfeeding without timing adjustments is generally considered safe.

When the Father Is Taking Prednisone

A less commonly asked but perfectly valid question is whether a father’s use of prednisone around the time of conception affects the baby. A nationwide cohort study examined birth outcomes in children fathered by men who filled prescriptions for systemic corticosteroids within three months before conception. The study found no significantly increased risk of preterm birth or small-for-gestational-age babies. There was a slight numerical increase in congenital anomalies among children whose fathers had filled two or more prescriptions shortly before conception, but the finding was not statistically significant.²¹ On the basis of current evidence, paternal prednisone use around conception does not appear to pose a meaningful risk to the pregnancy.

What Prednisone Cannot Protect Against

It is worth noting that all the safety discussion above applies to treating the mother’s conditions with prednisone. Corticosteroids serve a completely different purpose when they are given to accelerate fetal lung development before an expected preterm delivery. In that scenario, clinicians deliberately choose steroids like dexamethasone or betamethasone that cross the placenta efficiently, and the dosing, timing, and risk profile are entirely different from what is discussed in this article. The antenatal corticosteroid protocol for lung maturity is one of the most impactful interventions in perinatal medicine, but it answers a different question than whether a mother with lupus or asthma can safely take prednisone for her own health.

If you are pregnant and your doctor has prescribed or is considering prednisone, the decision ultimately comes down to a comparison: the known risks of your disease going untreated versus the generally manageable risks of low-dose steroid therapy. For most autoimmune and inflammatory conditions, the evidence consistently favors treating the disease. The key is keeping the dose as low as the disease allows, using steroid-sparing drugs where possible, and making sure your obstetric and specialist teams are communicating with each other about both the pregnancy and the underlying condition.